Delay in Regular Visits of Chronic Disease Patients and Its Associated Factors during the COVID-19 Pandemic.


Journal

Iranian journal of medical sciences
ISSN: 1735-3688
Titre abrégé: Iran J Med Sci
Pays: Iran
ID NLM: 8104374

Informations de publication

Date de publication:
03 2023
Historique:
received: 25 12 2021
revised: 16 03 2022
accepted: 26 04 2022
entrez: 10 3 2023
pubmed: 11 3 2023
medline: 14 3 2023
Statut: ppublish

Résumé

Chronic patients need regular follow-ups. During the COVID-19 pandemic, these regular visits can be affected. The delay of chronic patients and its contributing factors in their periodic visits during the COVID-19 pandemic are examined here. This cross-sectional study was conducted between February and June 2021, in Fars, Iran. Two hundred and eighty-six households with at least one chronic patient were recruited. Then, several trained questioners called the studied households and asked about the studied variables. The dependent variable was the number of delays in regular visits during the COVID-19 pandemic. The results were analyzed through Poisson regression by SPSS Statistics version 22 and GraphPad Prism software version 9. A significance level of 0.05 was considered for this study. Out of 286 households 113 (73.4%) fathers, 138 (70.1%) mothers, and 17 (58.6%) children in the households reported delayed referral. In fathers, referring to the health center was significantly associated with a decrease in the number of delays (P=0.033). The higher age of the householder (P=0.005), the higher number of children (P=0.043), and having a family physician (P=0.007) in the mothers' group, also the number of children in households (P=0.001) in the children group were significantly associated with increasing the number of delays. COVID-19 pandemic not only creates direct harmful effects but also adversely affects people in danger of chronic diseases. Delays in follow-ups are taken into account as a major challenge during the COVID-19 pandemic. This issue is not limited to rural or urban residency.

Sections du résumé

Background
Chronic patients need regular follow-ups. During the COVID-19 pandemic, these regular visits can be affected. The delay of chronic patients and its contributing factors in their periodic visits during the COVID-19 pandemic are examined here.
Methods
This cross-sectional study was conducted between February and June 2021, in Fars, Iran. Two hundred and eighty-six households with at least one chronic patient were recruited. Then, several trained questioners called the studied households and asked about the studied variables. The dependent variable was the number of delays in regular visits during the COVID-19 pandemic. The results were analyzed through Poisson regression by SPSS Statistics version 22 and GraphPad Prism software version 9. A significance level of 0.05 was considered for this study.
Results
Out of 286 households 113 (73.4%) fathers, 138 (70.1%) mothers, and 17 (58.6%) children in the households reported delayed referral. In fathers, referring to the health center was significantly associated with a decrease in the number of delays (P=0.033). The higher age of the householder (P=0.005), the higher number of children (P=0.043), and having a family physician (P=0.007) in the mothers' group, also the number of children in households (P=0.001) in the children group were significantly associated with increasing the number of delays.
Conclusion
COVID-19 pandemic not only creates direct harmful effects but also adversely affects people in danger of chronic diseases. Delays in follow-ups are taken into account as a major challenge during the COVID-19 pandemic. This issue is not limited to rural or urban residency.

Identifiants

pubmed: 36895456
doi: 10.30476/IJMS.2022.93944.2529
pii: IJMS-48-2
pmc: PMC9989245
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

176-186

Informations de copyright

Copyright: © Iranian Journal of Medical Sciences.

Déclaration de conflit d'intérêts

None declared.

Références

Eur Respir J. 2017 Aug 3;50(2):
pubmed: 28775050
JMIR Public Health Surveill. 2020 Jun 1;6(2):e19927
pubmed: 32452819
Emerg Infect Dis. 2016 Mar;22(3):433-41
pubmed: 26886846
Lancet Oncol. 2020 Aug;21(8):1023-1034
pubmed: 32702310
Crit Rev Clin Lab Sci. 2020 Sep;57(6):365-388
pubmed: 32645276
Int J Dermatol. 2021 Jul;60(7):860-863
pubmed: 33665815
J Card Fail. 2020 Jun;26(6):464-465
pubmed: 32417376
World J Plast Surg. 2013 Jan;2(1):18-25
pubmed: 25489500
Am J Emerg Med. 2021 Apr;42:242-243
pubmed: 32561139
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1621-1623
pubmed: 32889403
Can J Cardiol. 2020 Jun;36(6):915-930
pubmed: 32439306
Cancer Epidemiol Biomarkers Prev. 2004 May;13(5):723-32
pubmed: 15159302
Lancet Oncol. 2020 Aug;21(8):1035-1044
pubmed: 32702311
BMC Fam Pract. 2020 Oct 10;21(1):208
pubmed: 33038926
Eur J Clin Nutr. 2020 Jun;74(6):864-870
pubmed: 32404898
Lancet. 2016 Jan 2;387(10013):29-30
pubmed: 26766344
BMJ. 2020 May 13;369:m1931
pubmed: 32404318
Urology. 2021 Jan;147:50-56
pubmed: 32966822
Med J Islam Repub Iran. 2019 Apr 02;33:26
pubmed: 31380316
R Soc Open Sci. 2020 Oct 14;7(10):201199
pubmed: 33204475
Front Public Health. 2020 Jul 28;8:416
pubmed: 32850606
MEDICC Rev. 2019 Oct;21(4):53-58
pubmed: 32335570
Diabetes Care. 2005 Jan;28(1):186-212
pubmed: 15616254
Eur Heart J Qual Care Clin Outcomes. 2021 Jan 25;7(1):18-27
pubmed: 33151274
Int J Environ Res Public Health. 2020 Jul 02;17(13):
pubmed: 32630821
Diabetes Care. 2020 Nov;43(11):2870-2872
pubmed: 32778554
Lancet. 2012 Sep 15;380(9846):1011-29
pubmed: 22964159
Dela J Public Health. 2017 Mar 22;3(1):86-93
pubmed: 34466902
Med J Islam Repub Iran. 2020 Jul 15;34:80
pubmed: 33306040
Am Fam Physician. 2006 May 1;73(9):1558-68
pubmed: 16719248
MMWR Morb Mortal Wkly Rep. 2020 Sep 11;69(36):1250-1257
pubmed: 32915166
Am Heart J. 2004 Jul;148(1):7-15
pubmed: 15215786
Disaster Med Public Health Prep. 2022 Aug;16(4):1313-1314
pubmed: 33583480
Lancet Reg Health Eur. 2021 Jun 08;7:100144
pubmed: 34557845
Gastroenterology. 2020 Aug;159(2):772-774.e13
pubmed: 32376410
Acta Paediatr. 2020 Oct;109(10):2144-2146
pubmed: 32575149
Iran J Med Sci. 2012 Dec;37(4):253-9
pubmed: 23390331

Auteurs

Hassan Joulaei (H)

Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.

Zohre Foroozanfar (Z)

HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.

Arash Ziaee (A)

Department of Neuroscience, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Dariush Hooshyar (D)

Student Research Committee, School of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Mohammadjavad Loolia (M)

Deputy of Health Affairs, Shiraz University of Medical Sciences, Shiraz, Iran.

Fatemeh Azadian (F)

Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Maryam Fatemi (M)

HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH